The US Federal Trade Commission is investigating whether companies producing baby formula, including Abbott Laboratories, engaged in collusion during state contract bidding, as per a document published on the agency’s website.
The FTC is investigating potential collusion or coordination by the companies involved in the bidding, as stated in the document.
In 2022, the FTC initiated an investigation into possible collusion or coordination among bidders for the Women, Infants and Children (WIC) program, which provides free formula to low-income families on behalf of the U.S. Department of Agriculture.
According to the document, studies indicated that winning contracts not only generated revenue but also resulted in improved commercial sales.
Related: FTC & DOJ Are On Alert For Collusion In US Labor Markets
“Although the boost in non-WIC sales motivates manufacturers to win WIC contracts, it may also create incentives to engage in collusive or coordinated market allocation, whereby incumbent WIC contract holders agree not to bid against each other,” the document, written by Commissioner Alvaro Bedoya, said.
The antitrust agency requested information on the company’s formula sales that were not included in the program.
A spokesperson for Abbott said that the company was cooperating with the FTC’s information requests, and pointed out a filing to the FTC where the company said: “Abbott is unaware of any factual basis to support the WIC-related investigation, and staff have not identified any reason to believe that Abbott or any of its competitors have coordinated or colluded regarding any WIC contract.”
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI